Canaan Partners X LLC is 10% Owner at Protagonist Therapeutics, Inc (PTGX). They have made 5 open-market trades across 1 company since 2018, most recently 2021-12-31.
CIK 0001673228
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 60% | 60% |
| Avg Move | -18.3% | -17.9% | -15.6% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTGX | SELL | 2018-05-17 | 2018-05-21 | $6.09 | $475K | +12.8% | +12.2% | +43.4% |
| PTGX | SELL | 2018-05-14 | 2018-05-16 | $6.42 | $2.1M | +9.4% | +12.2% | +30.3% |
| PTGX | SELL | 2018-03-23 | 2018-03-26 | $20.71 | $2.5M | +0.6% | -0.8% | -20.2% |
| PTGX | SELL | 2018-03-16 | 2018-03-19 | $20.55 | $837K | -58.2% | -56.6% | -64.8% |
| PTGX | SELL | 2018-03-13 | 2018-03-15 | $20.65 | $514K | -56.0% | -56.4% | -66.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.